NeoGenomics shareholders approve 4.325M share increase to 2023 Equity Plan, all directors re-elected

NEOGENOMICS INC

Amendment to 2023 Equity Incentive Plan approved: +4.325M shares, 1-year minimum vesting, no liberal share recycling.
All nine director nominees elected; votes ranged from 93.7% to 99.1% support (excluding broker non-votes).
Advisory say-on-pay passed with 81.77% of votes cast; board adopted annual frequency for future votes.
Ratification of Deloitte & Touche as auditor received 99.86% of votes cast.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.